Literature DB >> 24861185

Mechanisms, impact and management of pain in rheumatoid arthritis.

David A Walsh1, Daniel F McWilliams1.   

Abstract

People with rheumatoid arthritis (RA) identify pain as their most important symptom, one that often persists despite optimal control of inflammatory disease. RA pain arises from multiple mechanisms, involving inflammation, peripheral and central pain processing and, with disease progression, structural change within the joint. Consequently, RA pain has a wide range of characteristics-constant or intermittent, localized or widespread-and is often associated with psychological distress and fatigue. Dominant pain mechanisms in an individual are identified by critical evaluation of clinical symptoms and signs, and by laboratory and imaging tests. Understanding these mechanisms is essential for effective management, although evidence from preclinical models should be interpreted with caution. A range of pharmacological analgesic and immunomodulatory agents, psychological interventions and surgery may help manage RA pain. Pain contributes importantly to the clinical assessment of inflammatory disease activity, and noninflammatory components of RA pain should be considered when gauging eligibility for or response to biologic agents. Further randomized controlled trials are required to determine the optimal usage of analgesics in RA, and novel agents with greater efficacy and lower propensity for adverse events are urgently needed. Meanwhile, targeted use of existing treatments could reduce pain in people with RA.

Entities:  

Mesh:

Year:  2014        PMID: 24861185     DOI: 10.1038/nrrheum.2014.64

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  163 in total

1.  Endogenous opiate response to pain in rheumatoid arthritis and cortical and subcortical response to pain in normal volunteers using positron emission tomography.

Authors:  A K Jones; Q Liyi; V V Cunningham; D W Brown; S Ha-Kawa; T Fujiwara; K F Friston; S Silva; S K Luthra; T Jones
Journal:  Int J Clin Pharmacol Res       Date:  1991

Review 2.  Pain, catastrophizing, and depression in the rheumatic diseases.

Authors:  Robert R Edwards; Christine Cahalan; Christine Calahan; George Mensing; Michael Smith; Jennifer A Haythornthwaite
Journal:  Nat Rev Rheumatol       Date:  2011-02-01       Impact factor: 20.543

3.  Spinal tumor necrosis factor alpha neutralization reduces peripheral inflammation and hyperalgesia and suppresses autonomic responses in experimental arthritis: a role for spinal tumor necrosis factor alpha during induction and maintenance of peripheral inflammation.

Authors:  Michael Karl Boettger; Konstanze Weber; David Grossmann; Mieczyslaw Gajda; Reinhard Bauer; Karl-Jürgen Bär; Steffen Schulz; Andreas Voss; Christian Geis; Rolf Bräuer; Hans-Georg Schaible
Journal:  Arthritis Rheum       Date:  2010-05

4.  Coping with rheumatoid arthritis pain in daily life: within-person analyses reveal hidden vulnerability for the formerly depressed.

Authors:  Tamlin S Conner; Howard Tennen; Alex J Zautra; Glenn Affleck; Stephen Armeli; Judith Fifield
Journal:  Pain       Date:  2006-08-14       Impact factor: 6.961

Review 5.  A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities.

Authors:  Thaddeus W W Pace; Christine M Heim
Journal:  Brain Behav Immun       Date:  2010-10-08       Impact factor: 7.217

Review 6.  Towards a mechanism-based approach to pain management in osteoarthritis.

Authors:  Anne-Marie Malfait; Thomas J Schnitzer
Journal:  Nat Rev Rheumatol       Date:  2013-09-17       Impact factor: 20.543

Review 7.  Mechanisms of pain in arthritis.

Authors:  Hans-Georg Schaible; Andrea Ebersberger; Gisela Segond Von Banchet
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

Review 8.  The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review.

Authors:  Bethan L Richards; Samuel L Whittle; Désirée M van der Heijde; Rachelle Buchbinder
Journal:  J Rheumatol Suppl       Date:  2012-09

9.  Does acetaminophen activate endogenous pain inhibition in chronic fatigue syndrome/fibromyalgia and rheumatoid arthritis? A double-blind randomized controlled cross-over trial.

Authors:  Mira Meeus; Kelly Ickmans; Filip Struyf; Linda Hermans; Kevin Van Noesel; Jorinde Oderkerk; Luc S Declerck; Greta Moorkens; Guy Hans; Sofie Grosemans; Jo Nijs
Journal:  Pain Physician       Date:  2013 Mar-Apr       Impact factor: 4.965

10.  Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.

Authors:  R A Fava; N J Olsen; G Spencer-Green; K T Yeo; T K Yeo; B Berse; R W Jackman; D R Senger; H F Dvorak; L F Brown
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  70 in total

1.  Cystathionine-γ-lyase ameliorates the histone demethylase JMJD3-mediated autoimmune response in rheumatoid arthritis.

Authors:  Weijun Wu; Ming Qin; Wanwan Jia; Zheng Huang; Zhongzheng Li; Di Yang; Mengwei Huang; Chenxi Xiao; Fen Long; Jianchun Mao; Philip K Moore; Xinhua Liu; Yi Zhun Zhu
Journal:  Cell Mol Immunol       Date:  2018-05-29       Impact factor: 11.530

2.  The important role of central sensitization in chronic musculoskeletal pain seen in different rheumatic diseases.

Authors:  Mehmet Akif Guler; Omer Faruk Celik; Fikriye Figen Ayhan
Journal:  Clin Rheumatol       Date:  2019-08-24       Impact factor: 2.980

Review 3.  Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.

Authors:  Aitziber Buqué; Norma Bloy; Fernando Aranda; Isabelle Cremer; Alexander Eggermont; Wolf Hervé Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2016-03-10       Impact factor: 8.110

Review 4.  Calcitonin gene-related peptide in the joint: contributions to pain and inflammation.

Authors:  David A Walsh; Paul I Mapp; Sara Kelly
Journal:  Br J Clin Pharmacol       Date:  2015-07-22       Impact factor: 4.335

5.  The analgesic effect and possible mechanisms by which koumine alters type II collagen-induced arthritis in rats.

Authors:  Gui-Lin Jin; Jian Yang; Wan-Qing Chen; Jie Wang; Hong-Qiang Qiu; Ying Xu; Chang-Xi Yu
Journal:  J Nat Med       Date:  2018-07-27       Impact factor: 2.343

Review 6.  Fatigue in Rheumatoid Arthritis.

Authors:  Patricia Katz
Journal:  Curr Rheumatol Rep       Date:  2017-05       Impact factor: 4.592

7.  Neuronal FcγRI mediates acute and chronic joint pain.

Authors:  Li Wang; Xiaohua Jiang; Qin Zheng; Sang-Min Jeon; Tiane Chen; Yan Liu; Heather Kulaga; Randall Reed; Xinzhong Dong; Michael J Caterina; Lintao Qu
Journal:  J Clin Invest       Date:  2019-06-18       Impact factor: 14.808

8.  Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes.

Authors:  Polly J Bingley; Diane K Wherrett; Ann Shultz; Lisa E Rafkin; Mark A Atkinson; Carla J Greenbaum
Journal:  Diabetes Care       Date:  2018-04       Impact factor: 19.112

Review 9.  Non-inflammatory Causes of Pain in Patients with Rheumatoid Arthritis.

Authors:  Sean D Boyden; Imtiyaz N Hossain; Alyssa Wohlfahrt; Yvonne C Lee
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

Review 10.  Chronic Pain in Patients with Rheumatoid Arthritis.

Authors:  Kristen Mathias; Abhimanyu Amarnani; Neha Pal; Jay Karri; Daniel Arkfeld; Jonathan M Hagedorn; Alaa Abd-Elsayed
Journal:  Curr Pain Headache Rep       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.